Wag! Group Co. (PET)
NASDAQ (NMS) NASDAQ (NMS) Primary 
Grey Matters Health to open first NovaScan Neuroimaging Clinic in September
Grey Matters Health (CSE:GREY, OTCQB:AGNPD, FRA:AGW0) announced that it will be opening its first NovaScan Neuroimaging Clinic in September, marking the start of the company's planned US expansion focused on brain-specific PET imaging. The company described the facility as the first of its kind in the US dedicated to providing brain-specific PET scans for the detection of Alzheimer's disease and other neurodegenerative diseases, including frontotemporal dementia, Parkinson's disease and Lewy body dementia.
Grey Matters Health expands brain imaging services – ICYMI
Grey Matters Health (CSE:GREY, OTCQB:AGNPD, FRA:AGW0) earlier this week announced the arrival of its dedicated brain PET scanning system at the company's flagship clinic in Davie, Florida, representing a key operational milestone ahead of the facility's planned opening. During an interview with Proactive, chief executive Christopher Moreau said the clinic will focus exclusively on brain imaging, differentiating the company from conventional imaging providers that rely on large hybrid PET/CT systems designed to scan the entire body.
Grey Matters Health takes delivery of first brain-dedicated PET scanner for Florida clinic
Grey Matters Health (CSE:GREY, OTCQB:AGNPD, FRA:AGW0) announced that it has taken delivery of its first brain-dedicated positron emission tomography (PET) scanner for its NovaScan Neuroimaging Clinics flagship location in Davie, Florida, as the company prepares to open what it says will be the first US clinic focused exclusively on brain-only PET imaging. The company said the clinic will provide brain PET scans to support the early detection of Alzheimer's disease through beta-amyloid imaging, while also offering imaging services for other neurodegenerative conditions.
Telix Pharmaceuticals Limited (TLX) Discusses Physician Perspectives on Innovations in PSMA PET CT Imaging for Prostate Cancer Transcript
Telix Pharmaceuticals Limited (TLX) Discusses Physician Perspectives on Innovations in PSMA PET CT Imaging for Prostate Cancer Transcript
Algernon Health secures key investment and partners for PET rollout
Vancouver-based Algernon Health (CSE:AGN, OTCQB:AGNPF) is charting a new course in healthcare, setting its sights on one of the fastest-growing frontiers: neuroimaging for Alzheimer's disease. Once a drug-repurposing company known as Algernon Pharmaceuticals, the firm has pivoted into medtech, unveiling a brain-focused PET scanner and laying the groundwork for a network of dedicated imaging centers across North America.
Algernon Health strikes US neuroimaging deal with AMI, closes first tranche of private placement
Algernon Health (CSE:AGN, OTCQB:AGNPF) said on Monday it has signed a strategic business and investment agreement with US-based American Molecular Imaging (AMI) to provide exclusive radiology reading services for its planned network of brain-focused PET neuroimaging clinics in the US. Algernon said the facilities, slated to begin opening in early 2026, will be the first dedicated brain-optimized PET neuroimaging clinics in the country, aimed at early detection of Alzheimer's disease as well as other dementias, epilepsy, neuro-oncology and movement disorders.
Wag! Group Co. (PET) Q1 2025 Earnings Call Transcript
Wag! Group Co. (NASDAQ:PET ) Q1 2025 Earnings Conference Call May 12, 2025 8:30 AM ET Company Participants Greg Robles - IR Garrett Smallwood - CEO and Chairman Adam Storm - President and Chief Product Officer Alec Davidian - CFO Operator Good morning. Welcome to the Wag!
Wag! Group Co. (PET) Q4 2024 Earnings Call Transcript
Wag! Group Co. (NASDAQ:PET ) Q4 2024 Earnings Conference Call March 24, 2025 8:30 AM ET Company Participants Greg Robles - IR Garrett Smallwood - Chairman & CEO Adam Storm - President & Chief Product Officer Alec Davidian - CFO Conference Call Participants Jeremy Hamblin - Craig-Hallum Operator Good morning, and welcome to the Wag! Fourth Quarter and Full-Year 2024 Earnings Conference Call.
Wag! Group Co. (PET) Q3 2024 Earnings Call Transcript
Wag! Group Co. (NASDAQ:PET ) Q3 2024 Results Conference Call November 13, 2024 8:30 AM ET Company Participants Greg Robles - Investor Relations Garrett Smallwood - Chief Executive Officer Adam Storm - President and Chief Product Officer Alec Davidian - Chief Financial Officer Conference Call Participants Ryan Meyers - Lake Street Capital Markets Jeremy Hamblin - Craig-Hallum Matthew Koranda - ROTH Capital Operator Good morning, and welcome to the Wag! Third Quarter 2024 Earnings Conference Call.
Wag! Group Co. (PET) Reports Q3 Loss, Lags Revenue Estimates
Wag! Group Co. (PET) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.06 per share a year ago.
Wag! Group Co. (PET) Q2 2024 Earnings Call Transcript
Wag! Group Co. (NASDAQ:PET ) Q2 2024 Earnings Conference Call August 7, 2024 4:30 PM ET Company Participants Greg Robles – Investor Relations Garrett Smallwood – Chief Executive Officer Adam Storm – President and Chief Product Officer Alec Davidian – Chief Financial Officer Conference Call Participants Jason Helfstein – Oppenheimer Jeremy Hamblin – Craig-Hallum Matthew Koranda – ROTH Capital Operator Good afternoon, and welcome to the Wag! Second Quarter 2024 Earnings Conference Call.
Wag! Group Co. (PET) Reports Q2 Loss, Tops Revenue Estimates
Wag! Group Co. (PET) came out with a quarterly loss of $0.06 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.09 per share a year ago.
